PMC:7402624 / 37277-37677
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T343 | 121-125 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T344 | 254-257 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
| T345 | 283-288 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T346 | 335-340 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1352 | 261-265 | Gene | denotes | CD38 | Gene:952 |
| 1353 | 277-280 | Gene | denotes | CD4 | Gene:920 |
| 1366 | 89-97 | Species | denotes | patients | Tax:9606 |
| 1367 | 226-234 | Species | denotes | patients | Tax:9606 |
| 1368 | 319-327 | Species | denotes | patients | Tax:9606 |
| 1378 | 80-88 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T290 | 80-88 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T623 | 121-125 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T624 | 261-265 | http://purl.obolibrary.org/obo/PR_000001408 | denotes | CD38 |
| T625 | 271-288 | http://purl.obolibrary.org/obo/CL_0000895 | denotes | naïve CD4 T cells |
| T626 | 335-340 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T266 | 258-260 | Chemical | denotes | DR | http://purl.obolibrary.org/obo/CHEBI_73445 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T215 | 17-196 | Sentence | denotes | We then used the range of this variation over time to identify COVID-19 patients with changes in immune cell subpopulations beyond that expected in healthy subjects (see methods). |
| T216 | 197-392 | Sentence | denotes | Using this approach, ~50% of patients had an increase in HLA-DR+CD38+ non-naïve CD4 T cells over time, whereas in ~30% of patients, these cells were stable and, in ~20%, they decreased (Fig. 5E). |